AllStripes
VerifiedA research platform designed for rare diseases, where patients can contribute to research and accelerate drug development.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$200—300m (Dealroom.co estimates Aug 2021.)
San Francisco California (HQ)
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 230 % | 293 % | 3 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor investor | $0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Recent News about AllStripes
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.